Brazil Will Test in Humans 1st National mRNA Vaccine and Wants to Use Cancer Technology
4 Articles
4 Articles
Brazil will test in humans first mRNA vaccine with 100% national technology Bernardo Portella Brazil will test in humans, for the first time, a vaccine developed with messenger RNA technology (mRNA). The immunizer created by Fiocruz against Covid-19 has just received authorization from the National Health Surveillance Agency (Anvisa) to advance the clinical study. Researchers explain that the advance goes beyond the immunizer and changes the sce…
Immunizing Fiocruz against Covid-19 receives support from Anvisa and opens the way for use of the Brazilian platform in research against cancer, dengue, malaria and Chagas disease
Brazil advances in the development of its own technologies for the production of vaccines. The Ministry of Health announced on Wednesday (2) that Fiocruz will initiate clinical trials in humans of a vaccine against Covid-19 developed entirely in the country with messenger RNA technology (mRNA).Immunizer is the result of a partnership between Fiocruz and the Institute of Technology in Immunobiologicals (Bio-Manguinhos).Before reaching the clinica…
After authorization from Anvisa, recruitment of volunteers for the first phase of the study against Covid is planned to start in the first trimester of 2027
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
